Hamel Associates’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
Other funds holding CVS
Hamel Associates's CVS Position: Q1 2018 in Review
Hamel Associates sold out of CVS Health (CVS) in Q1 2018, closing a stake of 10,475 shares — an estimated $759K sold.
Hamel Associates first reported a position in CVS in Q2 2017 and held it in 3 quarters. The position peaked at $1.45M in Q3 2017. 1,550 funds tracked by Wall St. Rank hold CVS as of Q1 2018.
- Hamel Associates reported no remaining CVS Health position as of Q1 2018 after selling out during the quarter.
- Hamel Associates sold 10,475 CVS Health shares in Q1 2018, an estimated $759K.
- Hamel Associates first reported a position in CVS Health in Q2 2017 and held it in 3 quarters.
- Hamel Associates's CVS Health position peaked at $1.45M in Q3 2017.
- 1,550 funds tracked by Wall St. Rank held CVS Health as of Q1 2018.
Based on Hamel Associates's 13F filing for Q1 2018, filed 3 May 2018.